Uncovering the molecular secrets of inflammatory breast cancer biology : an integrated analysis of three distinct affymetrix gene expression datasets

van Laere, Steven J.; Ueno, Naoto T.; Finetti, Pascal; Vermeulen, Peter; Van Dam, Peter; Dirix, Luc; et al.

doi:10.1158/1078-0432.CCR-12-2549

Title

Uncovering the molecular secrets of inflammatory breast cancer biology : an integrated analysis of three distinct affymetrix gene expression datasets

Author

van Laere, Steven J.

Ueno, Naoto T.

Finetti, Pascal

Vermeulen, Peter

Van Dam, Peter

Dirix, Luc

et al.

Abstract

Background: Inflammatory breast cancer (IBC) is a poorly characterized form of breast cancer. So far, the results of expression profiling in IBC are inconclusive due to various reasons including limited sample size. Here, we present the integration of three Affymetrix expression datasets collected through the World IBC Consortium allowing us to interrogate the molecular profile of IBC using the largest series of IBC samples ever reported. Experimental Design: Affymetrix profiles (HGU133-series) from 137 patients with IBC and 252 patients with non-IBC (nIBC) were analyzed using unsupervised and supervised techniques. Samples were classified according to the molecular subtypes using the PAM50-algorithm. Regression models were used to delineate IBC-specific and molecular subtype-independent changes in gene expression, pathway, and transcription factor activation. Results: Four robust IBC-sample clusters were identified, associated with the different molecular subtypes (P < 0.001), all of which were identified in IBC with a similar prevalence as in nIBC, except for the luminal A subtype (19% vs. 42%; P < 0.001) and the HER2-enriched subtype (22% vs. 9%; P < 0.001). Supervised analysis identified and validated an IBC-specific, molecular subtype-independent 79-gene signature, which held independent prognostic value in a series of 871 nIBCs. Functional analysis revealed attenuated TGF-β signaling in IBC. Conclusion: We show that IBC is transcriptionally heterogeneous and that all molecular subtypes described in nIBC are detectable in IBC, albeit with a different frequency. The molecular profile of IBC, bearing molecular traits of aggressive breast tumor biology, shows attenuation of TGF-β signaling, potentially explaining the metastatic potential of IBC tumor cells in an unexpected manner. Clin Cancer Res; 19(17); 468596. ©2013 AACR.

Language

English

Source (journal)

Clinical cancer research. - Philadelphia, Pa, 1995, currens

Publication

Philadelphia, Pa : Association for Cancer Research , 2013

ISSN

1078-0432 [print]

1557-3265 [online]

DOI

10.1158/1078-0432.CCR-12-2549

Volume/pages